NCT01239797 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 321
- group Id
- BG001
- value
- 325
- group Id
- BG002
- value
- 646
- units
- Participants
- groups
- description
- Lenalidomide: Capsules, Oral, 25 mg, once daily, on Days 1-21 Repeat every 28 days until participants met criteria for discontinuation of study drug Dexamethasone (Oral): On weeks without Elotuzumab dosing: Tablets, Oral, 40mg Repeat every 28 days until participants met criteria for discontinuation of study drug On weeks with Elotuzumab dosing: Tablets, Oral, 28 mg Repeat every 28 days until participants met criteria for discontinuation of study drug Dexamethasone (IV): On weeks without Elotuzumab dosing: Not Applicable (N/A) On weeks with Elotuzumab dosing: Solution, Intravenous (IV), 8 mg, weekly Repeat every 28 days until participants met criteria for discontinuation of study drug Elotuzumab (BMS-901608; HuLuc63): Solution, IV, 10 mg/kg, weekly, on Days 1, 8, 15, 22 (cycles 1\&2); Days 1 and 15 (cycles 3 and beyond) Repeat every 28 days until participants met criteria for discontinuation of study drug
- id
- BG000
- title
- Lenalidomide + Dexamethasone + Elotuzumab
- description
- Lenalidomide: Capsules, Oral, 25 mg, once daily, on Days 1-21 Regimen repeated every 28 days until participants met criteria for discontinuation of study drug Dexamethasone: Tablets, Oral, 40 mg, weekly, on Days 1, 8, 15, 22 Regimen repeated every 28 days until participants met criteria for discontinuation of study drug
- id
- BG001
- title
- Lenalidomide + Dexamethasone
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 9.34
- value
- 66.2
- group Id
- BG001
- spread
- 10.26
- value
- 65.3
- group Id
- BG002
- spread
- 9.81
- value
- 65.7
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 134
- group Id
- BG001
- value
- 142
- group Id
- BG002
- value
- 276
- title
- < 65 years old
- measurements
- group Id
- BG000
- value
- 119
- group Id
- BG001
- value
- 122
- group Id
- BG002
- value
- 241
- title
- >= 65 and < 75 years old
- measurements
- group Id
- BG000
- value
- 68
- group Id
- BG001
- value
- 61
- group Id
- BG002
- value
- 129
- title
- >= 75 years old
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Age, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 129
- group Id
- BG001
- value
- 132
- group Id
- BG002
- value
- 261
- title
- Female
- measurements
- group Id
- BG000
- value
- 192
- group Id
- BG001
- value
- 193
- group Id
- BG002
- value
- 385
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 5
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 6
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 28
- group Id
- BG001
- value
- 33
- group Id
- BG002
- value
- 61
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 288
- group Id
- BG001
- value
- 291
- group Id
- BG002
- value
- 579
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 264
- group Id
- BG001
- value
- 280
- group Id
- BG002
- value
- 544
- title
- White
- measurements
- group Id
- BG000
- value
- 13
- group Id
- BG001
- value
- 10
- group Id
- BG002
- value
- 23
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 33
- group Id
- BG001
- value
- 31
- group Id
- BG002
- value
- 64
- title
- Asian
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 9
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 13
- title
- Other
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- title
- Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- population Description
- Randomized: all participants randomized to any treatment group
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 321
- group Id
- BG001
- value
- 325
- group Id
- BG002
- value
- 646
- units
- Participants
- groups
- description
- Lenalidomide: Capsules, Oral, 25 mg, once daily, on Days 1-21 Repeat every 28 days until participants met criteria for discontinuation of study drug Dexamethasone (Oral): On weeks without Elotuzumab dosing: Tablets, Oral, 40mg Repeat every 28 days until participants met criteria for discontinuation of study drug On weeks with Elotuzumab dosing: Tablets, Oral, 28 mg Repeat every 28 days until participants met criteria for discontinuation of study drug Dexamethasone (IV): On weeks without Elotuzumab dosing: Not Applicable (N/A) On weeks with Elotuzumab dosing: Solution, Intravenous (IV), 8 mg, weekly Repeat every 28 days until participants met criteria for discontinuation of study drug Elotuzumab (BMS-901608; HuLuc63): Solution, IV, 10 mg/kg, weekly, on Days 1, 8, 15, 22 (cycles 1\&2); Days 1 and 15 (cycles 3 and beyond) Repeat every 28 days until participants met criteria for discontinuation of study drug
- id
- BG000
- title
- Lenalidomide + Dexamethasone + Elotuzumab
- description
- Lenalidomide: Capsules, Oral, 25 mg, once daily, on Days 1-21 Regimen repeated every 28 days until participants met criteria for discontinuation of study drug Dexamethasone: Tablets, Oral, 40 mg, weekly, on Days 1, 8, 15, 22 Regimen repeated every 28 days until participants met criteria for discontinuation of study drug
- id
- BG001
- title
- Lenalidomide + Dexamethasone
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 9.34
- value
- 66.2
- group Id
- BG001
- spread
- 10.26
- value
- 65.3
- group Id
- BG002
- spread
- 9.81
- value
- 65.7
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 134
- group Id
- BG001
- value
- 142
- group Id
- BG002
- value
- 276
- title
- < 65 years old
- measurements
- group Id
- BG000
- value
- 119
- group Id
- BG001
- value
- 122
- group Id
- BG002
- value
- 241
- title
- >= 65 and < 75 years old
- measurements
- group Id
- BG000
- value
- 68
- group Id
- BG001
- value
- 61
- group Id
- BG002
- value
- 129
- title
- >= 75 years old
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Age, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 129
- group Id
- BG001
- value
- 132
- group Id
- BG002
- value
- 261
- title
- Female
- measurements
- group Id
- BG000
- value
- 192
- group Id
- BG001
- value
- 193
- group Id
- BG002
- value
- 385
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 5
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 6
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 28
- group Id
- BG001
- value
- 33
- group Id
- BG002
- value
- 61
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 288
- group Id
- BG001
- value
- 291
- group Id
- BG002
- value
- 579
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 264
- group Id
- BG001
- value
- 280
- group Id
- BG002
- value
- 544
- title
- White
- measurements
- group Id
- BG000
- value
- 13
- group Id
- BG001
- value
- 10
- group Id
- BG002
- value
- 23
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 33
- group Id
- BG001
- value
- 31
- group Id
- BG002
- value
- 64
- title
- Asian
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 9
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 13
- title
- Other
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- title
- Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- population Description
- Randomized: all participants randomized to any treatment group
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle